Alvotech Gets FDA Approval for Second AVT02 Manufacturing Suite
Alvotech receives FDA approval to manufacture AVT02 drug substance in its second Reykjavik production suite.
Commercial Drug Substance Manufacturing | 06/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy